SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : C3 ( CTHR ) Diamond in the rough?
CTHR 0.400+100.0%Oct 31 12:16 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Linda Pearson who wrote (99)5/20/1998 5:14:00 PM
From: Leslie S. Feinberg  Read Replies (1) of 226
 
Linda;

Thanks for the reference on the C3 article. The most important sentences for me were,"C3 is a rarity -- a start-up company that people can pretty easily understand, with a product ready to come to market. That distinguishes it from many fledgling companies that are making a drug you can't pronounce that can't be sold until after a decade of clinical trials and regulatory back and forth."

There may still be skeptics in the investing community, hence the current share valuation; but I think by this winter we will see rapidly rising share prices. This stock will be a big winner in the next couple of years.
Les
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News